Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Brenner

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reports|January 1, 1980
Severe skin necrosis produced by piperazinedione extravasationD E Brenner, J Aisner, P H Wiernik
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Effect of sublethal liver injury on doxorubicin metabolismD A August, S Halter, D E Brenner
Primary Care|June 18, 1998
Cancer chemoprevention. A new way to treat cancer before it happensK Krishnan, M T Ruffin, D E Brenner
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agentK Krishnan, M T Ruffin, D E Brenner
Cancer Investigation|January 1, 1990
Noninvasive technology assessment: how should treatment of ovarian carcinoma be assessed?D E Brenner, S Schoeppel, J A Roberts
Anticancer Research|March 1, 1989
Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell linesB K Chang, D E Brenner, R Gutman
Cancer Chemotherapy and Pharmacology|January 27, 1998
Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administrationM G Sturgill, D E Brenner, D A August
Annals of Internal Medicine|July 1, 1983
Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issuesM P Carey, T G Burish, D E Brenner
Cancer Treatment Reports|April 1, 1986
Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitroE N Dessypris, D E Brenner, K R Hande
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbitsD E Brenner, J C Collins, K R Hande
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reports|January 1, 1980
Severe skin necrosis produced by piperazinedione extravasationD E Brenner, J Aisner, P H Wiernik
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Effect of sublethal liver injury on doxorubicin metabolismD A August, S Halter, D E Brenner
Primary Care|June 18, 1998
Cancer chemoprevention. A new way to treat cancer before it happensK Krishnan, M T Ruffin, D E Brenner
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agentK Krishnan, M T Ruffin, D E Brenner
Cancer Investigation|January 1, 1990
Noninvasive technology assessment: how should treatment of ovarian carcinoma be assessed?D E Brenner, S Schoeppel, J A Roberts
Anticancer Research|March 1, 1989
Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell linesB K Chang, D E Brenner, R Gutman
Cancer Chemotherapy and Pharmacology|January 27, 1998
Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administrationM G Sturgill, D E Brenner, D A August
Annals of Internal Medicine|July 1, 1983
Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issuesM P Carey, T G Burish, D E Brenner
Cancer Treatment Reports|April 1, 1986
Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitroE N Dessypris, D E Brenner, K R Hande
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbitsD E Brenner, J C Collins, K R Hande
Pageof 9